文献速递消化道肿瘤与早癌

循环IGF1与IGFBP3水平与结直肠癌风险的关联:血清学与孟德尔随机化分析

Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.
PubMed 文献 · Gastroenterology · 2019-12-27

研究基于英国生物银行397,380名参与者的血样,检测血清IGF1水平并随访至2016年3月31日,中位随访7.1年记录2665例结直肠癌。多变量校正模型显示IGF1每升高1个标准差,结直肠癌风险HR为1.11(95%CI 1.05-1.17)。两样本孟德尔随机化分析(52,865例病例与46,287例对照)显示遗传预测的IGF1每升高1个标准差OR为1.08(95%CI 1.03-1.12;P=3.3×10-4),遗传预测的IGFBP3每升高1个标准差OR为1.12(95%CI 1.06-1.18;P=4.2×10-5)。

要点

  • 血清IGF1水平升高与结直肠癌风险增加相关,HR为1.11(95%CI 1.05-1.17)。
  • 遗传预测的IGF1和IGFBP3水平升高均与结直肠癌风险增加相关。
  • IGFBP3基因区域仅rs11977526一个变异与结直肠癌风险相关。

核心结论

  • 循环IGF1水平与结直肠癌风险相关,遗传因素决定的IGF1水平升高与结直肠癌风险增加相关。
  • 需进一步研究该信号通路如何参与结直肠癌发生。

研究设计与样本

  • 在英国生物银行397,380名参与者中检测血清IGF1水平,血样采集于2006至2010年,随访至2016年3月31日。
  • 采用两样本孟德尔随机化分析,使用全基因组关联研究联盟数据(52,865例结直肠癌病例与46,287例对照)。

主要发现

  • 中位随访7.1年记录2665例结直肠癌。
  • 多变量校正模型中,IGF1每升高1个标准差,结直肠癌风险HR为1.11(95%CI 1.05-1.17),按性别、随访时间和肿瘤亚部位结果相似。
  • 孟德尔随机化分析中,遗传预测的IGF1每升高1个标准差,结直肠癌风险OR为1.08(95%CI 1.03-1.12;P=3.3×10-4)。
  • 遗传预测的IGFBP3每升高1个标准差,结直肠癌风险OR为1.12(95%CI 1.06-1.18;P=4.2×10-5)。
  • IGFBP3基因区域仅rs11977526一个变异与结直肠癌风险相关,该变异也与人体测量学特征及循环IGF2水平相关。

临床怎么用

  • 提示IGF1/IGFBP3信号通路可能作为结直肠癌风险评估的潜在生物学标志,但尚需进一步研究确认因果关系与机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Human studies examining associations between circulating levels of insulin-like growth factor 1 (IGF1) and insulin-like growth factor binding protein 3 (IGFBP3) and colorectal cancer risk have reported inconsistent results. We conducted complementary serologic and Mendelian randomization (MR) analyses to determine whether alterations in circulating levels of IGF1 or IGFBP3 are associated with colorectal cancer development. METHODS: Serum levels of IGF1 were measured in blood samples collected from 397,380 participants from the UK Biobank, from 2006 through 2010. Incident cancer cases and cancer cases recorded first in death certificates were identified through linkage to national cancer and death registries. Complete follow-up was available through March 31, 2016. For the MR analyses, we identified genetic variants associated with circulating levels of IGF1 and IGFBP3. The association of these genetic variants with colorectal cancer was examined with 2-sample MR methods using genome-wide association study consortia data (52,865 cases with colorectal cancer and 46,287 individuals without [controls]) RESULTS: After a median follow-up period of 7.1 years, 2665 cases of colorectal cancer were recorded. In a multivariable-adjusted model, circulating level of IGF1 associated with colorectal cancer risk (hazard ratio per 1 standard deviation increment of IGF1, 1.11; 95% confidence interval [CI] 1.05-1.17). Similar associations were found by sex, follow-up time, and tumor subsite. In the MR analyses, a 1 standard deviation increment in IGF1 level, predicted based on genetic factors, was associated with a higher risk of colorectal cancer risk (odds ratio 1.08; 95% CI 1.03-1.12; P = 3.3 × 10-4). Level of IGFBP3, predicted based on genetic factors, was associated with colorectal cancer risk (odds ratio per 1 standard deviation increment, 1.12; 95% CI 1.06-1.18; P = 4.2 × 10-5). Colorectal cancer risk was associated with only 1 variant in the IGFBP3 gene region (rs11977526), which also associated with anthropometric traits and circulating level of IGF2. CONCLUSIONS: In an analysis of blood samples from almost 400,000 participants in the UK Biobank, we found an association between circulating level of IGF1 and colorectal cancer. Using genetic data from 52,865 cases with colorectal cancer and 46,287 controls, a higher level of IGF1, determined by genetic factors, was associated with colorectal cancer. Further studies are needed to determine how this signaling pathway might contribute to colorectal carcinogenesis.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Murphy N, Carreras-Torres R, Song M, et al. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Gastroenterology. 2019. PMID: 31884074. doi:10.1053/j.gastro.2019.12.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。